Asian News International reported Nov. 18 on research in which Dr. Gal Bitan, Associate Professor of Neurology at UCLA, and colleagues used an innovative compound known as a "molecular tweezer" in a mouse model to break up the toxic aggregations of proteins that afflict the brain in Alzheimer's disease. Bitan was quoted.
Dr. Gal Bitan, Associate Professor in Residence of Neurology, David Geffen School of Medicine at UCLA, was featured in the Nov. 15 Examiner.com about his development of a molecular compound dubbed a "tweezer" that, in a living mouse model of Alzheimer's, for the first time cleared the toxic proteins that have been linked to Alzheimer's disease.
Dr. Liana Apostolova, Associate Professor-In-Residence of Neurology and a faculty member of UCLA's Mary S. Easton Center for Alzheimer's Disease Research, was featured Sept. 5 by KABC-Channel 7 on so-called "super-agers" -- elderly people whose cognitive processes have not slowed.
Dr. Gregory Cole, Professor of Medicine and Neurology and Associate Director of the Mary S. Easton Center for Alzheimer's Disease Research, was quoted in a Sept. 2 HealthDay News article about research indicating that the herbal supplement ginkgo biloba won't prevent or delay Alzheimer's.
- Comments on science from the Alzheimer's Association International Conference (AAIC) 2012
- Local radio station discusses mental illness in the black community.
- 1 in 8 of Alzheimer's PATIENTS WITH DELIRIUM face complications.
- Brain scan for Alzheimer's - A recently approved plaque-tracking dye can improve doctors' ability to identify Alzheimer's.